Recurrent squamous carcinoma of the vulva

A. S. Tilmans, G. P. Sutton, K. Y. Look, Frederick Stehman, C. E. Ehrlich, N. B. Hornback

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objective: This study reviews experience at Indiana University with recurrent squamous carcinoma of the vulva over an 18-year period from 1971 to 1989. The pattern of recurrence, time interval to recurrence, and efficacy of salvage therapy are evaluated in the context of the primary tumor. Study design: This is a retrospective study of 40 patients, 21 of whom underwent primary therapy for invasive squamous carcinoma of the vulva at Indiana University. Results: Vulvar recurrences were observed in 17 patients (43%), the groin was involved in 12 (30%), whereas pelvic and distant recurrences were observed in 2 (5%) and 9 (22.5%) patients, respectively. Salvage surgery and/or radiotherapy were successful in 25 patients (62.5%) alive from 1 to 144 months (median 8 months) from secondary therapy. Survival after retreatment varied significantly by site of recurrence (p = 0.002), tumor grade (p = 0.009), and interval to recurrence (p < 0.001). Best outcomes were in patients with initial stage I or II disease (International Federation of Gynecology and Obstetrics), grade 1 tumors, local failure, and interval to relapse of > 16 months' duration. Two of 12 patients with groin recurrences were salvaged with surgery and radiotherapy. Conclusion: Long-term follow-up of patients with vulvar cancer and careful restaging at the time of recurrence are mandatory. Although local and nodal recurrences may be controlled with surgery and/or radiotherapy, regional recurrences are usually fatal.

Original languageEnglish
Pages (from-to)1383-1389
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume167
Issue number5
StatePublished - 1992

Fingerprint

Vulva
Squamous Cell Carcinoma
Recurrence
Radiotherapy
Groin
Vulvar Neoplasms
Salvage Therapy
Retreatment
Neoplasms
Retrospective Studies

Keywords

  • recurrence
  • vulvar cancer

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Tilmans, A. S., Sutton, G. P., Look, K. Y., Stehman, F., Ehrlich, C. E., & Hornback, N. B. (1992). Recurrent squamous carcinoma of the vulva. American Journal of Obstetrics and Gynecology, 167(5), 1383-1389.

Recurrent squamous carcinoma of the vulva. / Tilmans, A. S.; Sutton, G. P.; Look, K. Y.; Stehman, Frederick; Ehrlich, C. E.; Hornback, N. B.

In: American Journal of Obstetrics and Gynecology, Vol. 167, No. 5, 1992, p. 1383-1389.

Research output: Contribution to journalArticle

Tilmans, AS, Sutton, GP, Look, KY, Stehman, F, Ehrlich, CE & Hornback, NB 1992, 'Recurrent squamous carcinoma of the vulva', American Journal of Obstetrics and Gynecology, vol. 167, no. 5, pp. 1383-1389.
Tilmans AS, Sutton GP, Look KY, Stehman F, Ehrlich CE, Hornback NB. Recurrent squamous carcinoma of the vulva. American Journal of Obstetrics and Gynecology. 1992;167(5):1383-1389.
Tilmans, A. S. ; Sutton, G. P. ; Look, K. Y. ; Stehman, Frederick ; Ehrlich, C. E. ; Hornback, N. B. / Recurrent squamous carcinoma of the vulva. In: American Journal of Obstetrics and Gynecology. 1992 ; Vol. 167, No. 5. pp. 1383-1389.
@article{b593dae11d6041868894c5c92b13f88d,
title = "Recurrent squamous carcinoma of the vulva",
abstract = "Objective: This study reviews experience at Indiana University with recurrent squamous carcinoma of the vulva over an 18-year period from 1971 to 1989. The pattern of recurrence, time interval to recurrence, and efficacy of salvage therapy are evaluated in the context of the primary tumor. Study design: This is a retrospective study of 40 patients, 21 of whom underwent primary therapy for invasive squamous carcinoma of the vulva at Indiana University. Results: Vulvar recurrences were observed in 17 patients (43{\%}), the groin was involved in 12 (30{\%}), whereas pelvic and distant recurrences were observed in 2 (5{\%}) and 9 (22.5{\%}) patients, respectively. Salvage surgery and/or radiotherapy were successful in 25 patients (62.5{\%}) alive from 1 to 144 months (median 8 months) from secondary therapy. Survival after retreatment varied significantly by site of recurrence (p = 0.002), tumor grade (p = 0.009), and interval to recurrence (p < 0.001). Best outcomes were in patients with initial stage I or II disease (International Federation of Gynecology and Obstetrics), grade 1 tumors, local failure, and interval to relapse of > 16 months' duration. Two of 12 patients with groin recurrences were salvaged with surgery and radiotherapy. Conclusion: Long-term follow-up of patients with vulvar cancer and careful restaging at the time of recurrence are mandatory. Although local and nodal recurrences may be controlled with surgery and/or radiotherapy, regional recurrences are usually fatal.",
keywords = "recurrence, vulvar cancer",
author = "Tilmans, {A. S.} and Sutton, {G. P.} and Look, {K. Y.} and Frederick Stehman and Ehrlich, {C. E.} and Hornback, {N. B.}",
year = "1992",
language = "English",
volume = "167",
pages = "1383--1389",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Recurrent squamous carcinoma of the vulva

AU - Tilmans, A. S.

AU - Sutton, G. P.

AU - Look, K. Y.

AU - Stehman, Frederick

AU - Ehrlich, C. E.

AU - Hornback, N. B.

PY - 1992

Y1 - 1992

N2 - Objective: This study reviews experience at Indiana University with recurrent squamous carcinoma of the vulva over an 18-year period from 1971 to 1989. The pattern of recurrence, time interval to recurrence, and efficacy of salvage therapy are evaluated in the context of the primary tumor. Study design: This is a retrospective study of 40 patients, 21 of whom underwent primary therapy for invasive squamous carcinoma of the vulva at Indiana University. Results: Vulvar recurrences were observed in 17 patients (43%), the groin was involved in 12 (30%), whereas pelvic and distant recurrences were observed in 2 (5%) and 9 (22.5%) patients, respectively. Salvage surgery and/or radiotherapy were successful in 25 patients (62.5%) alive from 1 to 144 months (median 8 months) from secondary therapy. Survival after retreatment varied significantly by site of recurrence (p = 0.002), tumor grade (p = 0.009), and interval to recurrence (p < 0.001). Best outcomes were in patients with initial stage I or II disease (International Federation of Gynecology and Obstetrics), grade 1 tumors, local failure, and interval to relapse of > 16 months' duration. Two of 12 patients with groin recurrences were salvaged with surgery and radiotherapy. Conclusion: Long-term follow-up of patients with vulvar cancer and careful restaging at the time of recurrence are mandatory. Although local and nodal recurrences may be controlled with surgery and/or radiotherapy, regional recurrences are usually fatal.

AB - Objective: This study reviews experience at Indiana University with recurrent squamous carcinoma of the vulva over an 18-year period from 1971 to 1989. The pattern of recurrence, time interval to recurrence, and efficacy of salvage therapy are evaluated in the context of the primary tumor. Study design: This is a retrospective study of 40 patients, 21 of whom underwent primary therapy for invasive squamous carcinoma of the vulva at Indiana University. Results: Vulvar recurrences were observed in 17 patients (43%), the groin was involved in 12 (30%), whereas pelvic and distant recurrences were observed in 2 (5%) and 9 (22.5%) patients, respectively. Salvage surgery and/or radiotherapy were successful in 25 patients (62.5%) alive from 1 to 144 months (median 8 months) from secondary therapy. Survival after retreatment varied significantly by site of recurrence (p = 0.002), tumor grade (p = 0.009), and interval to recurrence (p < 0.001). Best outcomes were in patients with initial stage I or II disease (International Federation of Gynecology and Obstetrics), grade 1 tumors, local failure, and interval to relapse of > 16 months' duration. Two of 12 patients with groin recurrences were salvaged with surgery and radiotherapy. Conclusion: Long-term follow-up of patients with vulvar cancer and careful restaging at the time of recurrence are mandatory. Although local and nodal recurrences may be controlled with surgery and/or radiotherapy, regional recurrences are usually fatal.

KW - recurrence

KW - vulvar cancer

UR - http://www.scopus.com/inward/record.url?scp=0026486299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026486299&partnerID=8YFLogxK

M3 - Article

C2 - 1442996

AN - SCOPUS:0026486299

VL - 167

SP - 1383

EP - 1389

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -